归一化双能碘比值在灌注CT与双能CT的定量影像生物标志物中最能区分肾细胞癌亚型
本研究回顾性纳入51例患者共52个肾细胞癌(36个透明细胞型、16个非透明细胞型),术前或活检前均行灌注CT和双能CT检查。两种方法鉴别透明细胞型与非透明细胞型的诊断准确率无显著差异,但双能CT的体型特异性剂量估计较灌注CT低16倍;碘比值AUC为0.95,以63.72%为阈值时敏感度0.90、特异度0.86、准确率0.87。
要点
- 碘比值(ICC 0.85)与血容量(ICC 0.93)是重复性最好的参数,碘比值AUC达0.95。
- 碘比值阈值63.72%时,鉴别透明细胞型与非透明细胞型的敏感度0.90、特异度0.86、准确率0.87。
- 双能CT的体型特异性剂量估计较灌注CT低16倍(P<0.001),两者诊断准确率无显著差异。
核心结论
- 灌注CT与双能CT在区分肾细胞癌亚型方面诊断准确率相当且均较高。
- 由于双能CT辐射剂量显著更低,碘比值可能作为最佳独立预测因子使用。
研究设计与样本
- 回顾性研究,纳入2014年1月至2018年12月间术前或活检前同时行灌注CT和双能CT的51例患者共52个肾细胞癌(36个透明细胞型、16个非透明细胞型)。
- 由三名独立阅片者分别测量灌注CT的血流量、血容量和渗透性,以及双能CT的碘浓度和碘比值。
- 采用组内相关系数(ICC)评估阅片者间一致性,采用多因素logistic回归分析评估灌注CT与双能CT模型,并比较两种方法的体型特异性剂量估计。
关键影像表现/征象
- 血容量(ICC 0.93)和碘比值(ICC 0.85)是重复性最好的参数。
- 灌注CT与双能CT模型在所有阅片者中均为鉴别透明细胞型与非透明细胞型的显著模型(P<0.05)。
- 血容量和碘比值是非透明细胞型的独立预测因子(P<0.05)。
诊断标准与关键数值
- 碘比值鉴别透明细胞型与非透明细胞型的AUC为0.95。
- 以碘比值63.72%为阈值时,敏感度0.90、特异度0.86、准确率0.87。
- 灌注CT与双能CT的诊断准确率无显著差异(P>0.05)。
- 双能CT的体型特异性剂量估计较灌注CT低16倍(P<0.001)。
临床应用与阅片要点
- 双能CT碘比值可作为区分透明细胞型与非透明细胞型肾细胞癌的独立预测指标,且辐射剂量显著低于灌注CT。
- 阅片时关注血容量与碘比值两项重复性最好的参数,有助于亚型鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to assess and compare the diagnostic accuracy of perfusion CT (PCT) and dual-energy CT (DECT) in differentiating clear cell renal cell carcinoma (ccRCC) from non-ccRCC. MATERIALS AND METHODS. This retrospective study included 51 patients with 52 renal cell carcinomas (RCCs) (36 ccRCCs and 16 non-ccRCCs) who underwent both PCT and DECT before surgery or biopsy between January 2014 and December 2018. Three independent readers measured blood flow, blood volume (BV), and permeability using PCT and iodine concentration (IC) and iodine ratio using DECT. Interreader agreement was calculated using the intraclass correlation coefficient (ICC). Multivariable logistic regression analysis was performed to assess PCT and DECT models. Size-specific dose estimates of the two methods were compared. RESULTS. BV (ICC, 0.93) and iodine ratio (ICC, 0.85) were the most reproducible parameters. Both PCT and DECT were significant models (p < 0.05, all readers) for differentiating ccRCC from non-ccRCC. There was no significant difference in diagnostic accuracy between PCT and DECT (p > 0.05). BV and iodine ratio were independent predictors of nonccRCC (p < 0.05). However, the mean size-specific dose estimate was 16 times lower with DECT than with PCT (p < 0.001). The AUC of iodine ratio was 0.95, and sensitivity, specificity, and accuracy with an iodine ratio cutoff of 63.72% was 0.90, 0.86, and 0.87, respectively. CONCLUSION. PCT and DECT had comparable and high diagnostic accuracy in differentiating RCC subtypes; however, because of the significantly lower radiation dose of DECT, iodine ratio may be used as the best independent predictor.
引用
- Manoharan D, Netaji A, Diwan K, et al. Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT. AJR Am J Roentgenol. 2020. PMID: 33052738. doi:10.2214/AJR.19.22612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。